In previous studies, rs1481012 in ABCG2 has been associated with risk of hyperuricemia, gout, coronary artery disease (CAD), B-cell non-Hodgkin lymphoma (B-NHL), and chronic lymphocytic leukemia (CLL) [28–30]. This evidence concerns the gene ABCG2 and B-cell chronic lymphocytic leukemia.